Related Experiment Video

Updated: May 9, 2026

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
07:13

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

Published on: April 30, 2020

Metabolic remodeling in chronic heart failure

Jing Wang1, Tao Guo

  • 1Department of Cardiology, the First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.

Journal of Zhejiang University. Science. B
|July 31, 2013
PubMed

Insights

Chronic heart failure (CHF) involves metabolic remodeling, shifting from fatty acid (FA) to carbohydrate use, then back to FA oxidation. Improving metabolic capability is key for managing this heart condition.

Area of Science:

  • Cardiology
  • Metabolic Medicine
  • Biochemistry

Background:

  • Chronic heart failure (CHF) remains a significant health burden despite advances in management.
  • Metabolic remodeling is increasingly recognized as a key factor in CHF pathophysiology.
  • The precise mechanisms and characteristics of metabolic remodeling in CHF require further elucidation.

Purpose of the Study:

  • To explore the role of metabolic remodeling in the pathophysiology of chronic heart failure.
  • To investigate the shifts in substrate utilization and metabolic capability during CHF progression.
  • To understand the underlying mechanisms driving metabolic changes in heart failure.

Main Methods:

  • Review of experimental and clinical evidence on metabolic substrate availability in CHF.
  • Analysis of metabolic capability changes in the context of hyperadrenergic state and insulin resistance.
  • Comparative assessment of substrate selection versus metabolic capability improvement.

Main Results:

  • Metabolism in early CHF favors carbohydrate utilization over fatty acid (FA) oxidation.
  • Advanced CHF shows a shift back towards increased FA uptake and oxidation, driven by hyperadrenergic state and insulin resistance.
  • Evidence suggests enhanced metabolic capability may be more impactful than substrate preference.

Conclusions:

  • Metabolic remodeling, characterized by dynamic substrate shifts and altered metabolic capability, is central to CHF.
  • Understanding these metabolic changes offers potential therapeutic targets for CHF.
  • Improving the heart's overall metabolic function appears more critical than manipulating substrate alone.

More Related Videos

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...